Common diabetes drug shows promise as treatment for COVID-19 lung inflammation

Researchers establish the molecular mechanism for the anti-inflammatory exercise of diabetes drug metformin and, in mouse research, say it prevents lung inflammation in animals contaminated with SARS-CoV-2, the virus that causes COVID-19.

Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here